Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine

Go back to Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.35 +0.12 (1.30%)
Previous Close $9.23    52 Week High $9.23 
Open $9.35    52 Week Low $1.16 
Day High $9.41    P/E N/A 
Day Low $9.16    EPS $-0.30 
Volume 2,848,478       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.35 +0.12 (1.30%)
Previous Close $9.23    52 Week High $9.23 
Open $9.35    52 Week Low $1.16 
Day High $9.41    P/E N/A 
Day Low $9.16    EPS $-0.30 
Volume 2,848,478